Sat.Aug 26, 2023 - Fri.Sep 01, 2023

article thumbnail

Adult Attention-Deficit/Hyperactivity Disorder (ADHD): Current Treatment and Follow-up Recommendations 

University of Utah Family Medicine Residency

by Leila Noghrehchi, MD Currently many psychiatrists are struggling with the ability to take patients with newly or undiagnosed ADHD into their practices due to schedule congestion with maintenance and follow-up appointments. Many primary care providers (PCP) continue to be wary of prescribing stimulants due to concerns of misuse and cardiovascular risk.

PCP 52
article thumbnail

Should We Be Prescribing Cookware? A Potential Intervention for Iron Deficiency Anemia - Clinical Correlations

Clinical Correlations

By Marie T. Mazzeo Peer Reviewed Anemia poses a significant threat to public health and affects approximately 2 billion people, nearly one-quarter of the world’s population.1,2 Iron deficiency is the most common cause of anemia worldwide and is the most common nutrient deficiency. 1,2.

Clinic 59
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Wearables, Sensors, and Apps Part 2 – Development and Qualification of Digital Health Technologies in Drug and Biological Product Development

FDA Law Blog

By Adrienne R. Lenz, Principal Medical Device Regulation Expert — Following up on our first post discussing Digital Health Technologies (DHTs) ( here ), this post will focus on development and qualification of DHTs for use in clinical trials for drug development. Earlier this year, FDA hosted a public meeting, Understanding Priorities for the Use of Digital Health Technologies to Support Clinical Trials for Drug Development and Review , intended to bring together key stakeholders, such as patie

Clinic 59
article thumbnail

A video that teaches you how to talk about why we don’t need chest X-Rays in respiratory illnesses

PEMBlog

Did you know that chest X-Rays are not recommended for most children with respiratory problems such as bronchiolitis, asthma exacerbations, croup, or first-time wheezing. Choosing Wisely recommends that doctors and all medical providers have detailed conversations with patients and their families about why X-Rays are unlikely to give new information or provide any additional reassurance.

Illness 52
article thumbnail

Normalcy, Introspection, & the Experience of Serious Illness: Bill Gardner, Juliet Jacobsen, and Brad Stuart

GeriPal

Summary Transcript Summary How do people react when they hear they have a serious illness? Shock, “like a car is rushing straight at me” (says Bill Gardner on our podcast). After the shock? Many people strive, struggle, crawl even back toward a “ normal ” life. And some people, in addition or instead, engage in deep introspection on how to make meaning or live with or understand this experience of serious illness.

Illness 128
article thumbnail

A classic educational video about the dangers of Repetitive Read Syndrome

PEMBlog

Repetitive Read Syndrome is affecting Radiologists across the globe. Symptoms include dictations including the same phrasing and suggesting clinical correlation repeatedly. We can help our Radiology colleagues by avoiding unnecessary chest X-ray orders for most children with respiratory problems such as bronchiolitis, asthma exacerbations, croup, or first-time wheezing.

Asthma 52
article thumbnail

You don’t need X-Rays in a child with bronchiolitis, croup, asthma, or first time wheezing

PEMBlog

This is a blog post and a podcast episode designed to disseminate the important work of Choosing Wisely , an initiative of the the American Board of Internal Medicine Foundation, the goal of which is the spark conversations between clinicians and patients about what tests, treatments, and procedures are needed – and which ones are not. The Choosing Wisely Pediatric Emergency Medicine Recommendations The Choosing Wisely Campaign Toolkit Expert Contributors Michele Nypaver, MD University of Michig

Asthma 52
article thumbnail

Trading Partners May Exhale: FDA Releases Guidance Exercising a Year-Long Period of Enforcement Discretion Related to DSCSA Enforcement of Certain Provisions

FDA Law Blog

By Karla L. Palmer — On Friday, August 25, 2023, FDA released a much-anticipated Final Guidance titled, “Enhanced Drug Distribution Security Requirements Under Section 582(g)(1) of the Federal Food, Drug, and Cosmetic Act,” addressing FDA’s implementation of certain electronic interoperability provisions of the Drug Supply Chain Security Act (DSCSA), which were due to become effective on November 27, 2023.